The DAX posted a slight decline at the beginning of the week. At the close of trading on Xetra, the index stood at 25,374 points, representing a decrease of 0.1% compared to Friday’s closing figures. Despite this small drop for the week, the day was characterized by significant volatility in the market, and the performance of individual stocks varied widely.
In the healthcare and life sciences sector, companies such as Merck, Siemens Health, and Fresenius Medical Care saw substantial growth, trading up by two percent or more. Conversely, Rheinmetall experienced the sharpest decline, losing 1.6%. Additionally, Deutsche Telekom, Siemens Energy, and Volkswagen all recorded losses exceeding one percent.
Adding to the market drama was a takeover battle within the chemical industry. Evonik’s management rejected a proposed merger bid from BASF. This corporate move had varying impacts on the stocks: BASF reacted mildly, declining by 0.3%, while Evonik gained noticeably, rising by 1.4%.
Meanwhile, bond yields continued their ascent. The yield on 10-year German government bonds has now reached 3.65%, marking the highest level seen since the 2008 financial crisis. This trend is likely being driven by the continuously rising oil price; Brent crude (the North Sea variant) cost $107.50 per barrel on Monday afternoon, a 3.1% increase from the previous trading day’s close.
In currency markets, the Euro was slightly weaker on Monday afternoon. The exchange rate showed that one Euro purchased $1.1368, while the Dollar was trading for 0.8797 Euros.
